Tag: Edaravone

Every year, approximately 5,000 people in the U.S. receive a diagnosis of Amyotrophic Lateral Sclerosis (ALS), a progressive and fatal neurodegenerative disease. When faced with this news, many want to know, 'What is the best drug for ALS?' The answer is not a single drug, but a personalized treatment plan combining multiple medications and supportive therapies.

According to landmark clinical trials, Riluzole was associated with a statistically significant prolongation of survival for patients with Amyotrophic Lateral Sclerosis (ALS). This makes it the only widely available drug that prolongs survival in patients with ALS, a progressive neurodegenerative disease.